Otx2 controls neuron subtype identity in ventral tegmental area and antagonizes vulnerability to MPTP

Nature Neuroscience

Volumn 13, Issue 12, 2010, Pages 1481-1489

  Di Salvio, Michela ^a   Di Giovannantonio, Luca Giovanni ^a   Acampora, Dario ^a,b,c   Prosperi, Raffaele ^d   Omodei, Daniela ^a   Prakash, Nilima ^e,f   Wurst, Wolfgang ^e,f   Simeone, Antonio ^a,b,c  

^a CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^b European School of Molecular Medicine SEMM   (Italy)

^c INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^d UNIVERSITY OF SANNIO   (Italy)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DAT PROTEIN; GIRK2 PROTEIN; PROTEIN; TRANSCRIPTION FACTOR OTX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DOPAMINE UPTAKE; FEMALE; GENE EXPRESSION; MALE; MOLECULAR BIOLOGY; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ANIMALS; EMBRYONIC STEM CELLS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; MPTP POISONING; NEURONS; OTX TRANSCRIPTION FACTORS; VENTRAL TEGMENTAL AREA;

EID: 78650215729     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn.2661     Document Type: Article

References (50)

1. Björklund, A. & Lindvall, O. Dopamine-containing systems in the CNS. in Handbook of Chemical Neuroanatomy: Classical Transmitters in the CNS (eds. Biörklund, A. and Hökfelt, T.) 55-121 (Elsevier, Amsterdam, 1984).
2. Björklund, L.M. & Isacson, O. Regulation of dopamine cell type and transmitter function in fetal and stem cell transplantation for Parkinson's disease. Prog. Brain Res. 138, 411-420 (2002).
3. Dahlström, A. & Fuxe, K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. 62, 1-55 (1964).
4. Smidt, M.P. & Burbach, J.P. How to make a mesodiencephalic dopaminergic neuron. Nat. Rev. Neurosci. 8, 21-32 (2007).
5. Marín, F., Herrero, M.T., Vyas, S. & Puelles, L. Ontogeny of tyrosine hydroxylase mRNA expression in mid-and forebrain: neuromeric pattern and novel positive regions. Dev. Dyn. 234, 709-717 (2005).
6. Omodei, D. et al. Anterior-posterior graded response to Otx2 controls proliferation and differentiation of dopaminergic progenitors in the ventral mesencephalon. Development 135, 3459-3470 (2008).
7. Thompson, L., Barraud, P., Andersson, E., Kirik, D. & Björklund, A. Identifcation of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression and efferent projections. J. Neurosci. 25, 6467-6477 (2005).
8. Jellinger, K.A. The pathology of Parkinson′s disease. Adv. Neurol. 86, 55-72 (2001).
9. Prakash, N. & Wurst, W. Development of dopaminergic neurons in the mammalian brain. Cell. Mol. Life Sci. 63, 187-206 (2006).
10. Simeone, A. Genetic control of dopaminergic neuron differentiation. Trends Neurosci. 28, 62-65 (2005).
11. Saucedo-Cardenas, O. et al. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl. Acad. Sci. USA 95, 4013-4018 (1998)
12. Jankovic, J., Chen, S. & Le, W.D. The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease. Prog. Neurobiol. 77, 128-138 (2005).
13. Smidt, M.P. et al. A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nat. Neurosci. 3, 337-341 (2000).
14. Smidt, M.P. et al. Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3. Development 131, 1145-1155 (2004)
15. Kele, J. et al. Neurogenin 2 is required for the development of ventral midbrain dopaminergic neurons. Development 133, 495-505 (2006).
16. Ferri, A.L. et al. Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner. Development 134, 2761-2769 (2007).
17. Andersson, E., Jensen, J.B., Parmar, M., Guillemot, F. & Björklund, A. Development of the mesencephalic dopaminergic neuron system is compromised in the absence of neurogenin 2. Development 133, 507-516 (2006).
18. Andersson, E. et al. Identifcation of intrinsic determinants of midbrain dopamine neurons. Cell 124, 393-405 (2006).
19. Ono, Y. et al. Differences in neurogenic potential in foor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic foor plate cells. Development 134, 3213-3225 (2007).
20. van den Munckhof, P. et al. Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons. Development 130, 2535-2542 (2003).
21. Nunes, I., Tovmasian, L.T., Silva, R.M., Burke, R.E. & Goff, S.P. Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc. Natl. Acad. Sci. USA 100, 4245-4250 (2003)
22. Simon, H.H., Saueressig, H., Wurst, W., Goulding, M.D. & O'Leary, D.D. Fate of midbrain dopaminergic neurons controlled by the engrailed genes. J. Neurosci. 21, 3126-3134 (2001).
23. Sonnier, L. et al. Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1. J. Neurosci. 27, 1063-1071 (2007).
24. Sgadò, P. et al. Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice. Proc. Natl. Acad. Sci. USA 103, 15242-15247 (2006)
25. Zetterström, R.H. et al. Dopamine neuron agenesis in Nurr1-defcient mice. Science 276, 248-250 (1997).
26. Castelo-Branco, G. et al. Differential regulation of dopaminergic neuron development by Wnt-1, Wnt-3a and Wnt-5a. Proc. Natl. Acad. Sci. USA 100, 12747-12752 (2003)
27. Puelles, E. et al. Otx dose-dependent integrated control of antero-posterior and dorso-ventral patterning of midbrain. Nat. Neurosci. 6, 453-460 (2003).
28. Puelles, E. et al. Otx2 regulates the extent, identity and fate of neuronal progenitor domains in the ventral midbrain. Development 131, 2037-2048 (2004).
29. Prakash, N. et al. A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo. Development 133, 89-98 (2006).
30. Afonso-Oramas, D. et al. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease. Neurobiol. Dis. 36, 494-508 (2009).
31. Dauer, W. & Przedborski, S. Parkinson's disease: mechanisms and models. Neuron 39, 889-909 (2003).
32. Jackson-Lewis, V., Jakowec, M., Burke, R.E. & Przedborski, S. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 4, 257-269 (1995)
33. Blum, D. et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 65, 135-172 (2001).
34. Chung, C.Y. et al. Cell type-specifc gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. Hum. Mol. Genet. 14, 1709-1725 (2005).
35. Greene, J.G., Dingledine, R. & Greenamyre, J.T. Gene expression profling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism. Neurobiol. Dis. 18, 19-31 (2005).
36. Murer, G. et al. An immunocytochemical study on the distribution of two G-protein-gated inward rectifer potassium channels (GIRK2 and GIRK4) in the adult rat brain. Neuroscience 80, 345-357 (1997).
37. Schein, J.C., Hunter, D.D. & Roffer-Tarlov, S. Girk2 expression in the ventral midbrain, cerebellum, and olfactory bulb and its relationship to the murine mutation weaver. Dev. Biol. 204, 432-450 (1998).
38. Di Salvio, M., Di Giovannantonio, L.G., Omodei, D., Acampora, D. & Simeone, A. Otx2 expression is restricted to dopaminergic neurons of the ventral tegmental area in the adult brain. Int. J. Dev. Biol. 54, 939-945 (2010).
39. Liang, C.L., Sinton, C.M., Sonsalla, P.K. & German, D.C. Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration. Neurodegeneration 5, 313-318 (1996).
40. Roffer-Tarlov, S., Martin, B., Graybiel, A.M. & Kauer, J.S. Cell death in the midbrain of the murine mutation weaver. J. Neurosci. 16, 1819-1826 (1996).
41. Bäckman, C.M. et al. Characterization of a mouse strain expressing Cre recombinase from the 3′ untranslated region of the dopamine transporter locus. Genesis 44, 383-390 (2006).
42. Acampora, D., Di Giovannantonio, L.G., Di Salvio, M., Mancuso, P. & Simeone, A. Selective inactivation of Otx2 mRNA isoforms reveals isoform-specifc requirement for visceral endoderm anteriorization and head morphogenesis and highlights cell diversity in the visceral endoderm. Mech. Dev. 126, 882-897 (2009).
43. Kittappa, R., Chang, W.W., Awatramani, R.B. & McKay, R.D. The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old age. PLoS Biol. 5, e325 (2007).
44. Li, L.B. et al. The role of N-glycosylation in function and surface traffcking of the human dopamine transporter. J. Biol. Chem. 279, 21012-21020 (2004).
45. Torres, G.E. et al. Oligomerization and traffcking of the human dopamine transporter. Mutational analysis identifes critical domains important for the functional expression of the transporter. J. Biol. Chem. 278, 2731-2739 (2003).
46. Bezard, E. et al. Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter. Exp. Neurol. 155, 268-273 (1999).
47. Pif, C., Giros, B. & Caron, M.G. Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium. J. Neurosci. 13, 4246-4253 (1993).
48. Agoston, Z. & Schulte, D. Meis2 competes with the Groucho co-repressor Tle4 for binding to Otx2 and specifes tectal fate without induction of a secondary midbrain-hindbrain boundary organizer. Development 136, 3311-3322 (2009).
49. Kadkhodaei, B. et al. Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons. J. Neurosci. 29, 15923-15932 (2009).
50. Soriano, P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21, 70-71 (1999).